Product Information
EZETIMIBE 10 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.0715 per EA under NDC 16729043310. Its NADAC has been published 334 times since Jan 1, 2020.
The High Outlier badge above means this manufacturer's average price in the EZETIMIBE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729043310
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
5/20/2026
Active Ingredients
EZETIMIBEApproval Type
Generic (ANDA)
FDA Application
ANDA211550On Market Since
10/7/2019
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE 10 MG TABLET has been published 334 times since Jan 1, 2020, and over the history we have for it it has declined 66.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0715 per EA |
|---|---|
| All-time high | $0.2201 (Feb 12, 2020) |
| All-time low | $0.0687 (Oct 22, 2025) |
| 52-week high | $0.0763 |
| 52-week low | $0.0687 |
| Median price | $0.0951 |
| Average price | $0.1112 |
| Largest weekly change | +22.7% (Jun 19, 2024) |
| Weeks tracked | 334 |
| Tracking since | Jan 1, 2020 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EZETIMIBE 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE 10 MG TABLET, manufactured by Accord Healthcare Inc., is $0.0715 per EA (NDC 16729043310), effective May 20, 2026.
How has the price of EZETIMIBE 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for EZETIMIBE 10 MG TABLET has declined 66.2%. It has been tracked across 334 weekly CMS publications since Jan 1, 2020.
What are the highest and lowest recorded NADAC prices for EZETIMIBE 10 MG TABLET?
Since Jan 1, 2020, the NADAC for EZETIMIBE 10 MG TABLET has ranged from a low of $0.0687 (Oct 22, 2025) to a high of $0.2201 (Feb 12, 2020), with a median of $0.0951 per EA.
Are there cheaper alternatives to EZETIMIBE 10 MG TABLET?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, EZETIMIBE 10 MG TABLET, is $0.0691 per EA — about 3% below EZETIMIBE 10 MG TABLET.
Who manufactures EZETIMIBE 10 MG TABLET?
EZETIMIBE 10 MG TABLET (NDC 16729043310) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification